BACKGROUND: The purpose of this study was to evaluate the long-term efficacy and the safety of a lecithin-based delivery form of boswellic acids from Boswellia serrata (Casperome®) for the prevention of symptoms in otherwise healthy subjects with mild irritable bowel syndrome (IBS). MET HODS: The study included 69 otherwise healthy participants...
-
2019 (v1)PublicationUploaded on: April 14, 2023
-
2019 (v1)Publication
BACKGROUND: In this pilot non-interference clinical study we evaluated possible interactions between Quercetin Phytosome® (Quercefit™), an innovative delivery form of quercetin, and antiplatelet agents, anticoagulants, and anti-diabetic therapy in otherwise healthy subjects. METHODS: Interaction with antiplatelet therapy was assessed through...
Uploaded on: April 14, 2023